Lv3
248 积分 2023-05-15 加入
Refractory Membranous Nephropathy With Anti-Rituximab Antibodies Treated Successfully With Obinutuzumab
2小时前
求助中
Obinutuzumab versus rituximab for the treatment of refractory primary membranous nephropathy
5小时前
已完结
236-P: The HLA DRβ13 residue is associated with the development of human anti-chimeric antibody in some Crohn's patients treated with infliximab
13天前
已完结
Causality between diabetes and membranous nephropathy: Mendelian randomization
17天前
已完结
Incidence and pathological features of IgA nephropathy before and during the COVID-19 pandemic
17天前
已完结
Comparison of obinutuzumab and rituximab for treating primary membranous nephropathy
1个月前
已完结
Obinutuzumab in untreated primary membranous nephropathy: An observational case series
1个月前
已完结
Combined Serologic and Genetic Risk Score and Prognostication of Phospholipase A2 receptor-Associated Membranous Nephropathy
1个月前
已完结
Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20
1个月前
已关闭
CD20: a regulator of cell-cycle progression of B lymphocytes
1个月前
已完结
皖公网安备34019202002308
